Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

NIH 2

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Endometrial Neoplasms 2Uveal Melanoma 1Thyroid Neoplasms 1Leukemia 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Specimen Handling 10Magnetic Resonance Spectroscopy 9Carboplatin 9Taxes 7Paclitaxel 7Biopsy 7temsirolimus 6Trastuzumab 5Sirolimus 5pembrolizumab 4Radiotherapy 4olaparib 3Nivolumab 3Interleukin-12 Subunit p35 3Bevacizumab 3pertuzumab 2palbociclib 2ipatasertib 2binimetinib 2aldesleukin 2X-Rays 2Thalidomide 2Reverse Transcriptase Polymerase Chain Reaction 2Oxaliplatin 2Megestrol Acetate 2Interleukin-12 2Immunoglobulin G 2Fluorouracil 2Docetaxel 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Endometrial Neoplasms × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT01150682 2011-04-29

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

National Cancer Institute (NCI)

Unknown
865 enrolled
Gynecologic

Endometrial Neoplasms

NCT01119573 2010-06-22

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer

National Cancer Institute (NCI)

Unknown
100 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡